SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony@Pacific who wrote (3107)11/6/2000 8:49:03 PM
From: StockDung  Read Replies (1) of 5582
 
"Another recent study showed that zinc lozenges were useless in warding off colds in children. Sponsored by Quigley Corp., a Pennsylvania manufacturer of zinc lozenges, researchers enrolled 249 suburban Cleveland students in grades one through 12. Half began taking zinc lozenges within 24 hours of developing a cold, while half took placebos."

"Cold symptoms and duration of illness were the same in both groups. But the lead researcher said the problem may have been that dosages were too low, or even that the flavoring in the lozenges somehow deactivated the zinc."

"And now the manufacturer is challenging the results, saying 83 of the youngsters should have been disqualified for various reasons. "The data that resulted from the study provides no meaningful conclusion," the company said."
Message 14740743
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext